atricure.com (ATRC): Operating Profitability

AtriCure Corp (ATRC) - corporate logo

AtriCure, Inc. (ATRC) is protected by exclusive patents and stringent FDA controls, which is confirmed by the change in operating margin on the GURU.Markets chart, where 3.10 describes the current status of the metric. Revenue growth is based on the implementation of minimally invasive systems and the legal protection of rights. High demand for cardiac devices guarantees stable cash flows that are virtually independent of economic shocks.

ATRC - AtriCure Operating Profit Ratio over the range 07/04/2022 - 11/19/2026

Analytical breakdowns and data insights for company AtriCure (ATRC)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental valuation:ATRC, AtriCure Corp
Finished products of atricure.com

Operating margin determines the share of profit from core operations relative to total revenue before accounting for financial expenses and taxes. For AtriCure, Inc. (ATRC), this metric reflects the efficiency of commercializing robotic cryoablation systems and automated surgical instrumentation. By analyzing the core business margin, an investor assesses the company's ability to control costs while scaling production. The indicator's trend demonstrates the model's resilience to price shocks. A stable profitability level confirms the high quality of the issuer's assets.

Competitor analysis for AtriCure, Inc.

ISRG (intuitive.com) - Operating Margin|Return on Sales by Operating Profit DHR (Danaher Corp.)|Operating Sales Margin BDX (Becton, Dickinson and Company)|Operating Profit Ratio STE|Operating Profitability West Pharma WST|Profitability of Operations Baxter (BAX)|MASI - Operating Profitability|Profitability of Operations Stevanato Group Corp STVN|TFX: Operating Margin|Operating Sales Margin Merit Medical Systems|Operating Profitability Envista Holdings Corp|Operating Sales Margin ICU Medical Corp (ICUI)|Operating Profitability DENTSPLY SIRONA Inc. (XRAY)|Operating Sales Margin LeMaitre LMAT|Operating Margin STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Operating Return on Sales|ZimVie Inc - Operating Margin|Operating Return on Sales AngioDynamics|CERS (Cerus Corp) - Operating Sales Margin|Alpha Teknova, Inc. - Operating Profit Rate|MGRM (Monogram Orthopedics Inc.) - Operating Margin|STSS: Operating Profit Rate|Operating Sales Margin INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Return on Sales by Operating Profit|Operating Margin KRMD (korumedical.com)|Profitability of Operations Nyxoah, S.A. (NYXH)|MBOT - Operating Profitability|PDEX (Pro-Dex, Inc.) - Return on Sales by Operating Profit|ZTEK (Zentek Ltd) - Operating Sales Margin|ELUT - Profitability of Operations|MLSS (Milestone Scientific Corporation) - Operating Margin|Return on Sales by Operating Profit NXGL (NEXGEL, Inc.)|Operating Margin RVP|Operating Sales Margin Harvard Bioscience HBIO|Operating Margin FEMY (Femasys Corporation)|MHUA - Operating Sales Margin|POAI - Operating Profitability|Callan JMB (CJMB) - Operating Sales Margin|ATRI: Operating Margin|NURO - Profitability of Operations